Janet Woodcock will become acting commissioner of the US Food and Drug Administration upon Commissioner Stephen Hahn’s departure on 20 January following the inauguration of President-elect Joe Biden, leaving the agency in the hands of a career veteran who has been a lead expert in the COVID-19 response.
The move was requested by the incoming Biden team, a senior FDA official confirmed to the Pink Sheet, and the...





